Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$819M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$550M |
| 3 |
Boston Scientific
BSX
|
+$303M |
| 4 |
ExxonMobil
XOM
|
+$291M |
| 5 |
Advanced Micro Devices
AMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$513M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Target
TGT
|
+$379M |
| 4 |
Eli Lilly
LLY
|
+$351M |
| 5 |
EOG Resources
EOG
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 11.16% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
2051
Apollo Commercial Real Estate
ARI
$892M
| $6.19M | ﹤0.01% |
591,425
-13,877
| -2% | -$170K |
|
2052
Astrana Health
ASTH
$1.78B
| $6.19M | ﹤0.01% |
160,360
+2,417
| +2% | +$91.9K |
|
2053
Valley National Bancorp
VLY
$8.02B
| $6.18M | ﹤0.01% |
593,685
-12,112
| -2% | -$144K |
|
2054
Werner Enterprises
WERN
$2.23B
| $6.18M | ﹤0.01% |
160,481
-3,030
| -2% | -$119K |
|
2055
Goldman Sachs BDC
GSBD
$993M
| $6.18M | ﹤0.01% |
369,729
-1,372
| -0.4% | -$25.3K |
|
2056
Payoneer
PAYO
$2.4B
| $6.18M | ﹤0.01% |
1,577,032
-513,030
| -25% | -$2.29M |
|
2057
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$605M
| $6.16M | ﹤0.01% |
117,561
-14,222
| -11% | -$779K |
|
2058
Aspen Aerogels
ASPN
$392M
| $6.15M | ﹤0.01% |
+622,901
| New | +$12.6M |
|
2059
e.l.f. Beauty
ELF
$4.87B
| $6.13M | ﹤0.01% |
199,749
-1,811
| -0.9% | -$45.5K |
|
|
HIE
2060
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $6.11M | ﹤0.01% |
656,842
+46,124
| +8% | +$479K |
|
2061
Canadian Pacific Kansas City
CP
$79.7B
| $6.11M | ﹤0.01% |
87,219
-123,300
| -59% | -$8.93M |
|
2062
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
| $6.11M | ﹤0.01% |
75,396
-90,317
| -55% | -$7.62M |
|
|
MNTX
2063
DELISTED
Manitex International, Inc.
MNTX
| $6.09M | ﹤0.01% |
937,930
-25,321
| -3% | -$184K |
|
|
CHNG
2064
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $6.09M | ﹤0.01% |
263,954
-380
| -0.1% | -$8.88K |
|
2065
Abercrombie & Fitch
ANF
$4.84B
| $6.07M | ﹤0.01% |
358,938
-33,265
| -8% | -$918K |
|
2066
First Trust STOXX European Select Dividend Income Fund
FDD
$894M
| $6.07M | ﹤0.01% |
558,703
-20,477
| -4% | -$255K |
|
2067
Gorman-Rupp
GRC
$2.19B
| $6.04M | ﹤0.01% |
213,510
-8,090
| -4% | -$252K |
|
2068
Grupo Cibest SA
CIB
$21.6B
| $6.04M | ﹤0.01% |
195,717
-8,507
| -4% | -$335K |
|
|
IAS
2069
DELISTED
Integral Ad Science
IAS
| $6.03M | ﹤0.01% |
+607,150
| New | +$7.24M |
|
2070
AdvanSix
ASIX
$542M
| $6.02M | ﹤0.01% |
180,105
-13,261
| -7% | -$592K |
|
2071
Xtrackers S&P 500 ESG ETF
SNPE
$2.69B
| $6.01M | ﹤0.01% |
176,052
+100,744
| +134% | +$3.73M |
|
2072
VanEck Merk Gold Trust
OUNZ
$2.51B
| $6M | ﹤0.01% |
342,483
+92,504
| +37% | +$1.68M |
|
2073
iShares US Transportation ETF
IYT
$2.26B
| $6M | ﹤0.01% |
112,712
-88,424
| -44% | -$5.14M |
|
2074
State Street SPDR ICE Preferred Securities ETF
PSK
$689M
| $5.99M | ﹤0.01% |
166,938
-198,244
| -54% | -$7.17M |
|
2075
Bio-Rad Laboratories Class A
BIO
$8.96B
| $5.98M | ﹤0.01% |
12,092
-8,839
| -42% | -$4.6M |
|
Similar funds
Ameriprise's Q2 2022 Portfolio in Review
As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
- Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
- Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
- Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
- Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
- Ameriprise opened 137 new positions and closed 191 in Q2 2022.
- Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.